We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

49 hedge funds and large institutions have $37.2M invested in Filana Therapeutics in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 19 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $15K | Put options by funds: $5K

5% more capital invested

Capital invested by funds: $35.6M → $37.2M (+$1.61M)

26% less funds holding

Funds holding: 66 → 49 (-17)

42% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 19

85% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 20

Holders
49
Holders Change
-17
Holders Change %
-25.76%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
11
Reduced
19
Closed
20
Calls
$15K
Puts
$5K
Net Calls
+$10K
Net Calls Change
+$12K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$1.67M
2
Renaissance Technologies
Renaissance Technologies
New York
+$138K
3
BCM
Bridgeway Capital Management
Texas
+$129K
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$66.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$64.2K

Top Sellers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
-$546K
2
Goldman Sachs
Goldman Sachs
New York
-$440K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$320K
4
MERSOM
Municipal Employees' Retirement System of Michigan
Michigan
-$141K
5
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$117K
Name Holding Trade Value Shares
Change 		Change in
Stake
First Eagle Investment Management
1
First Eagle Investment Management
New York
$10.4M – – –
NCM
2
Nantahala Capital Management
Connecticut
$8.3M +$39.9K +3,158 +0.5%
JGC
3
J. Goldman & Co
New York
$2.92M -$55.8K -4,419 -2%
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.5M +$64.2K +5,085 +3%
BIT
5
BlackRock Institutional Trust
California
$2.37M -$9.43K -747 -0.4%
BI
6
BVF Inc
California
$1.7M +$1.67M +132,680 New
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$1.29M -$26K -2,063 -2%
Renaissance Technologies
8
Renaissance Technologies
New York
$1.09M +$138K +10,957 +15%
6CM
9
683 Capital Management
New York
$791K – – –
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$719K -$22.1K -1,749 -3%
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$649K -$12.2K -964 -2%
GIM
12
Granahan Investment Management
Massachusetts
$613K -$4.92K -390 -0.8%
BCM
13
Bridgeway Capital Management
Texas
$606K +$129K +10,200 +28%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$371K +$631 +50 +0.2%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$305K +$707 +56 +0.2%
GF
16
Gabelli Funds
New York
$293K -$9.01K -714 -3%
Goldman Sachs
17
Goldman Sachs
New York
$212K -$440K -34,851 -68%
Morgan Stanley
18
Morgan Stanley
New York
$210K -$18.8K -1,493 -8%
TA
19
Teton Advisors
New York
$203K – – –
BFA
20
BlackRock Fund Advisors
California
$186K -$4.85K -384 -3%
Millennium Management
21
Millennium Management
New York
$186K -$2.12K -168 -1%
California Public Employees Retirement System
22
California Public Employees Retirement System
California
$183K – – –
Northern Trust
23
Northern Trust
Illinois
$127K -$546K -43,238 -81%
GI
24
GAMCO Investors
Connecticut
$119K – – –
GS
25
Gagnon Securities
New York
$115K – – –
1
2 3

FLNA Hedge Fund Activity: Q3 2015 in Review

49 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2015, worth a combined $37.2M — up 4.5% from $35.6M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of FLNA and 3 opened new positions — a net loss of 17 holders — while 19 trimmed existing stakes and 11 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $1.67M. The largest seller was Northern Trust, cutting an estimated $546K.

  • 49 institutional investors held Filana Therapeutics (FLNA) as of Q3 2015, down from 66 in Q2 2015.
  • Funds reported $37.2M of Filana Therapeutics stock for Q3 2015, up 4.5% quarter-over-quarter.
  • 3 funds opened new Filana Therapeutics positions in Q3 2015 and 20 closed out, a net change of -17 holders.
  • The largest Filana Therapeutics buyer in Q3 2015 was BVF Inc, an estimated $1.67M added.
  • The largest Filana Therapeutics seller in Q3 2015 was Northern Trust, an estimated $546K sold.

Based on aggregated 13F filings for Q3 2015.